New York, USA – September 13, 2021 – Bispecific monoclonal antibodies are artificial proteins that can simultaneously bind to two same or different types of antigens. This dual specificity for soluble antigens has sparked intense interest of researchers who want to broaden therapeutic applications of bispecific antibodies in different fields. Creative Biolabs will host a webinar, which is the second session in its series of free webinars focused on the research of BsAbs, to discuss how to harness the power of bsAbs in cancer therapies and virus neutralization.
The upcoming webinar will feature presentations from:
* Archana Thakur, Associate Professor, Ph.D., School of Medicine Director, Human Cellular Therapeutics cGMP Core, at the University of Virginia, focusing on developing new and innovative therapeutic approaches in hematology and oncology to enhance clinical and anti-tumor immune responses.
* Luca Varani, Ph.D., the group leader of the Institute for Research in Biomedicine, Università della Svizzera italianaBellinzona, Switzerland, whose research focus is to understand interactions between pathogens and antibodies, as well as molecules of the immune system, involving rare and neglected diseases such as Dengue or Zika virus, prion diseases, and a rare form of Leukemias.
During this webinar, Dr. Thakur and Dr. Varani will introduce how they have utilized the power of bsAbs to 1) arm “headless CAR T cells” and serially kill tumor targets and 2) neutralize wild-type SARS-CoV-2 and its variants and suppress viral escape correspondingly, followed by a short question and answer session.
The webinar will take place on Thursday, October 14, 2021, 10: 00 AM Eastern Daylight Time (EDT) / October 14, 2021, 4:00 PM Central European Summer Time (CEST).
The webinar will be available for viewing with registration at any time afterwards.
About Creative Biolabs
Creative Biolabs has been dedicated to antibody discovery, engineering, production, and analysis for decades. With a group of experienced bispecific antibody experts and innovative techniques, Creative Biolabs is committed to advancing the applications of bispecific antibodies and provides high-quality bispecific molecules, including bispecific IgGs, appended IgGs, BsAb fragments, bispecific fusion proteins, and BsAb conjugates. Now it has become the supplier of choice for scientists across the globe.
More products, services, and resources of bispecific antibodies are available at: https://www.creative-biolabs.com/bsab.